InflaRx Set to Launch Phase 2 Trial Testing IFX-1 in AAV Patients Following FDA Approval – ANCA Vasculitis News

InflaRx Set to Launch Phase 2 Trial Testing IFX-1 in AAV Patients Following FDA Approval – ANCA Vasculitis News

InflaRx Set to Launch Phase 2 Trial Testing IFX-1 in AAV Patients Following FDA Approval – ANCA Vasculitis News
Published on 2018-07-03